be_ixf;ym_202009 d_28; ct_50

Select Page

The No. 1 Stock to Own in 2019

A lot of people are going to be surprised at this one.

I know they were surprised by my top 2018 stock pick, Foundation Medicine. After all, the stock sat for years. But I knew something they didn’t … that the company was primed for a buyout.

Sure enough, on June 19, 2018, Swiss pharmaceutical giant Roche bought the company. Shares soared 524%.

My subscribers excitedly shared their returns with me. Mike reeled in a whopping $1,109,307 from this stock alone. Laura and Frankie instantly profited $160,000. Chris made more than $58,000. And modest investors saw huge gains too – like Lenny, who turned his $1,000 investment into $3,000.

Now, my No. 1 pick for this year is in a completely different market.

The technology it’s developing will impact every single industry on the planet. Fidelity says it will “change the world.”

Billionaire investor Marc Andreessen calls it “the most important technology since the internet itself.”

Industry experts say spending on this technology will shoot from $4 billion to $3.1 trillion. That’s a 77,400% increase.

Imagine taking a $10 bill and watching it multiply into $7,740 with zero effort … That’s the potential of this market.

As for my No. 1 stock for 2019 – like most of my favorite picks, it’s underrated.

It’s still one of the cheapest stocks on the S&P 500. It’s down more than 40% from a recent high. And with a PE ratio of 3.15, it looks like it’s severely undervalued.

This stock is an absolute bargain right now. But it won’t be for long …

If you’re a bold investor who’s tired of the usual financial drones, you’ll love hearing about my No. 1 stock pick this year.

Click here to watch my full presentation now.

 

 

 

 

 

 


Legal Notice: This work is based on what we’ve learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It’s your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Don’t trade in these markets with money you can’t afford to lose. Investing in stock markets involves the risk of loss. Before investing you should consider carefully the risks involved, if you have any doubt as to suitability or the taxation implications, seek independent financial advice. Banyan Hill Publishing expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, Banyan Hill Publishing, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast or 72 hours after a publication only circulated through the mail.

(c) 2018 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 866-584-4096)

About Banyan Hill

Banyan Hill Publishing logo At Banyan Hill Publishing, we are a network of global experts in asset protection, investing and entrepreneurship who have united together to help hardworking Americans obtain the freedom of “total wealth” — the ability to make your own financial decisions, grow your wealth and be free from the financial concerns that plague so many of us.

Meeting Our Gurus

Paul Mampilly Charles Mizrahi Michael Carr, CMT, CFTe Ted Bauman Brian Christopher Chad Shoop, CMT Matt Badiali Ian King